In humans, a biallelic missense mutation (T536I) in ACT1 abolishes the homotypic interaction between IL-17R and ACT1, resulting in impaired IL-17 responses with chronic mucocutaneous candidiasis (97). The gene discussed is TRAF3IP2; the disease is Chronic mucocutaneous candidosis.